EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunogenicity of Wild Type and Mutant Hepatitis B Surface Antigen Virus-like Particles (VLPs) in Mice with Pre-Existing Immunity against the Wild Type Vector

Natalie J Kingston iD, Renae Walsh, Rachel Hammond, Carina C D Joe iD, George Lovrecz, Stephen Locarnini, Hans J Netter iD

Viruses · 2023

DOI: 10.3390/v15020313 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Natalie J Kingston und 6 weiteren Autor:innen. Beteiligte Einrichtung: Infection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, VIC 3800, Australia. Hauptthemen laut MEDLINE: Hepatitis B Surface Antigens, Immunogenicity, Vaccine, Malaria Vaccines, Plasmodium falciparum. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Centre for HIV and Viral Hepatitis Research (ACH2).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Virus-like particles (VLPs), composed of the small hepatitis B virus surface antigen (HBsAgS), are the antigenic components of the hepatitis B virus (HBV) vaccine and represent the backbones for a chimeric anti-malaria vaccine and various vaccine candidates. Biological vectors have to face pre-existing anti-vector immune responses due to previous immune exposure. Vector recognition after natural infections or vaccinations can result in unwarranted outcomes, with compromising effects on clinical outcomes. In order to evaluate the impact of a pre-existing anti-HBsAgS immune response, we developed mutant VLPs composed of subunits with reduced HBsAgS-specific antigenicity. The insertion of a Plasmodium falciparum circumsporozoite protein (CSP)-derived epitope as a read-out allowed the assessment of wild type (wt) and mutant VLPs in the context of a pre-existing immune response. Mutant and wt VLP platforms with a CSP-epitope insert are immunogenic and have the ability to generate anti-CSP antibody responses in both naïve BALB/c mice and mice with a pre-existing anti-HBsAgS immune response, but with superior anti-CSP responses in mice with a pre-existing immunity. The data indicate that previous HBsAgS exposure facilitates enhanced antibody responses against foreign epitopes delivered by the HBsAgS platform, and, in this context, the state of immune sensitization alters the outcome of subsequent vaccinations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hepatitis B Surface AntigensImmunogenicity, VaccineMalaria VaccinesPlasmodium falciparumVaccines, Virus-Like ParticleAnimalsMiceEpitopesMalariaMice, Inbred BALB CModels, AnimalVaccinationProtozoan Proteins

Stichwörter der Autor:innen

delivery platformshepatitis B surface antigen (HBsAg)immune sensitizationvectored vaccines

Substanzen

EpitopesHepatitis B Surface AntigensMalaria VaccinesVaccines, Virus-Like Particlecircumsporozoite protein, ProtozoanProtozoan Proteins

Autor:innen und Institutionen

  • Infection and Immunity Program, Monash Biomedicine Discovery Institute, Department of Microbiology, Monash University, Clayton, VIC 3800, Australia.
  • School of Molecular and Cellular Biology, Faculty of Biological Sciences, Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds LS2 9JT, UK.
  • Victorian Infectious Diseases Reference Laboratory (VIDRL), Melbourne Health, The Peter Doherty Institute, Melbourne, VIC 3000, Australia.
  • School of Science, Royal Melbourne Institute of Technology (RMIT) University, Melbourne, VIC 3001, Australia.
  • Commonwealth Scientific and Industrial Research Organisation, Clayton, VIC 3169, Australia.
  • Jenner Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.

ORCID-Profile: Natalie J Kingston, Carina C D Joe, Hans J Netter

Förderung

  • Australian Centre for HIV and Viral Hepatitis Research (ACH2)

Zitieren

APA

Kingston, N. J., Walsh, R., Hammond, R., Joe, C. C. D., Lovrecz, G., Locarnini, S., & Netter, H. J. (2023). Immunogenicity of Wild Type and Mutant Hepatitis B Surface Antigen Virus-like Particles (VLPs) in Mice with Pre-Existing Immunity against the Wild Type Vector. Viruses. https://doi.org/10.3390/v15020313

Vancouver

Kingston NJ, Walsh R, Hammond R, Joe CCD, Lovrecz G, Locarnini S, et al. Immunogenicity of Wild Type and Mutant Hepatitis B Surface Antigen Virus-like Particles (VLPs) in Mice with Pre-Existing Immunity against the Wild Type Vector. Viruses. 2023. doi:10.3390/v15020313

BibTeX
@article{Kingston2023,
  author = {Kingston, Natalie J and Walsh, Renae and Hammond, Rachel and Joe, Carina C D and Lovrecz, George and Locarnini, Stephen and Netter, Hans J},
  title = {Immunogenicity of Wild Type and Mutant Hepatitis B Surface Antigen Virus-like Particles (VLPs) in Mice with Pre-Existing Immunity against the Wild Type Vector},
  journal = {Viruses},
  year = {2023},
  doi = {10.3390/v15020313}
}
Kostenlos starten →